AMCLOX DRY COW INTRAMAMMARY INFUSION

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

지금 구매하세요

Download 환자 정보 전단 (PIL)
05-04-2023

유효 성분:

AMPICILLIN AS THE TRIHYDRATE; CLOXACILLIN AS THE BENZATHINE

제공처:

VETPHARM LABORATORIES IP PTY LTD

약제 형태:

MISC. INTRA MAMMARY

구성:

AMPICILLIN AS THE TRIHYDRATE ANTIBIOTIC Active 250.0 mg/sy; CLOXACILLIN AS THE BENZATHINE Active 500.0 mg/sy

패키지 단위:

20 x 3.8 g syringes; 200 x 3.8 g syringes

수업:

VM - Veterinary Medicine

치료 영역:

ANTIBIOTIC & RELATED

제품 요약:

Poison schedule: 4; Withholding period: MEAT: DO NOT USE less than 30 days befor e slaughter for human consumption. MI LK: DO NOT USE in lactating cows or with in 30 days of calving. After calving, co lostrum or milk from treated dry cows MU ST NOT BE USED or processed for human co nsumption for 96 hours (8 milkings). If premature or unscheduled calving occurs, consult the prescribing veterinarian fo r advice on handling milk for bobby calv es. Any variation by the prescribing veterinarian to the approved dose, frequ ency, duration, route, disease or target species may require an extended withhol ding period. An ESI has not been esta blished for this product. Note—observin g the meat withholding period may not be sufficient to mitigate potential risks to export trade. Trade advice should be sought from the distributor on 02 9810 1 104 before using this product.; Host/pest details: COW-NOT LACTATING-PREG. NOT W/I 1MTH CAL: [ANTIBIOTIC - ANTI-INFECTIVE]; DAIRY CATTLE DRY: [ANTIBIOTIC - ANTI-INFECTIVE]; DAIRY CATTLE LACTATING: [ANTIBIOTIC - ANTI-INFECTIVE]

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

                                AMCLOX DRY COW INTRAMAMMARY INFUSION
93158/138131
Product Name:
APVMA Approval No:
Label Name:
AMCLOX DRY COW INTRAMAMMARY INFUSION
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Each syringe contains:
500 mg CLOXACILLIN (as the Benzathine)
250 mg AMPICILLIN (as the Trihydrate)
Claims:
For treatment of bovine mastitis caused by organisms sensitive to
Ampicillin and Cloxacillin,
during the dry period.
Resistance may develop to any chemical. Indiscriminate use of AMCLOX
may contribute to
the development of antibiotic resistance.
Net Contents:
20 x 3.8 g syringes
200 x 3.8 g syringes
Directions for Use:
Restraints:
DO NOT USE in lactating cows or within 30 days of calving. If AMCLOX
is accidentally
administered to a lactating animal or within 30 days of calving,
contact your prescribing
veterinarian for advice.
Contraindications:
Contraindicated for use in cows with a history of allergic reaction to
penicillins.
Precautions:
Side Effects: RLP APPROVED
Dosage and
Administration:
Dose: One syringe per quarter immediately after the final milking of a
lactation.
Administration: At the final milking of a lactation, milk the cow
normally. Clean and disinfect
the teat ends using rubbing alcohol or iodophors or other suitable
cleanser. Infuse the
contents of one syringe into each quarter and leave without further
milking. Wear clean
rubber gloves when applying. Dip all teats after infusion, in an
approved teat disinfection.
General Directions:
Product Summary
AMCLOX DRY COW INTRAMAMMARY INFUSION is formulated for routine
treatment of
cows at drying off.
AMCLOX is broad spectrum in activity and active against all the major
causative organisms
of mastitis.
AMCLOX is active against penicillin resistant Staphylococci, commonly
involved in mastitis.
The formulation and base provide effective concentrations in the udder
to eliminate the
majority of existing infections and to reduce substantially the
incidence of new infections.
Description
AMCLOX is a st
                                
                                전체 문서 읽기